PDGFRβ was enriched in fibrotic areas, although its expression was increased by BMMSC-sEV treatment at 24 h, but it was reduced after 4 weeks of myocardial infarction, which may be the reason for the antifibrotic effects of sEVs. This evidence concerns the gene PDGFRB and myocardial infarction.